All articles tagged with #preclinical studies
This review explores the potential of glucagon-like peptide-1 (GLP-1) receptor agonists as emerging treatments for bipolar disorder, summarizing preclinical and clinical evidence supporting their therapeutic role in mood regulation, neuroprotection, and metabolic health.
Researchers at Case Western Reserve University and Cleveland Clinic have developed a promising vaccine approach that has eliminated pancreatic cancer in preclinical models, showing potential for both treatment and prevention of this deadly disease, with plans to advance to clinical trials.
Life Biosciences is focused on targeting the underlying biology of ageing to restore and prolong healthspan, defined as the number of healthy years lived. By addressing biological mechanisms of ageing, such as epigenetic modifications, the company aims to develop therapeutics that can reverse ageing and treat age-related diseases. Their lead program utilizes partial epigenetic reprogramming to treat age-related optic neuropathies, with plans to initiate human clinical trials in 2025. Additionally, they are exploring the potential of cellular rejuvenation in treating neurodegenerative diseases and other age-related conditions.